Market Blog » The Arora Report Stock Market News

THE BUM AND THE BEAUTY: APPLE AND NETFLIX SWITCH ROLES $AAPL $NFLX $GOOG

January 23, 2013

It is a sign of the times. Call it a tale of two stocks after earnings. Both Apple (AAPL) and Netflix (NFLX) reported earnings after the close. It is said that a picture is worth 1,000 words. The chart tells the story better than any words can describe. There is a mind boggling 43% differential in the performance of the two stocks after hours. Just imagine if you were short Apple and long Netflix going into earnings, you would have realized a 43% gain in 90 minutes. Of course I was not clairvoyant enough to capture the trade. I came into the earnings

STOP ZONE ON FACEBOOK $FB

January 23, 2013

This post was just published on ZYX Short Sell Change Alert. Now there is a fill on FB for a 10% tranche. Consider a stop zone of $33.61 to $33.78.

THE SINGLE MOST IMPORTANT DATA POINT IN APPLE EARNINGS $AAPL

January 23, 2013

Apple will report first quarter earnings after the market close today. Apple has become a battleground stock. Earnings will provide lots of data but will not settle the debate about Apple’s future. The obvious question is, “What should investors do with the onslaught of data related to all things Apple?” The single most important data point to focus on is the number of iPhone sales. The consensus is 48 million. Most estimates range from 45 million to 50 million. The latest negative sentiment is bringing down the whisper numbers for iPhone sales. Some whisper numbers are in the range of 43

WORK AT APPLE, BE WITTY, HELP SIRI BLOSSOM $AAPL

January 21, 2013

I have been writing for some time that the pace of innovation at Apple was slowing. For a couple of months it was egg on my face as Apple stock continued to skyrocket into the launch of iPhone 5. After iPhone 5 was launched, slowly but surely investors started to recognize that iPhone 5 did not incorporate any breakthrough innovations like they had come to expect from Apple. The stock started to stumble and now has fallen about $200. The lesson for investors is that money in technology stocks is neither made by focusing on traditional fundamental analysis such as P/E ratios,

GOLD STAGES KEY BULLISH TECHNICAL REVERSAL $GLD $SLV $SLW $ABX $NEM,

January 18, 2013

On Thursday gold staged a bullish ‘outside day.’ In traditional technical analysis, an outside day is traced when the low of the day is lower than the previous day’s low and the high of the day is higher than the previous day’s high. Candlestick or OHLC chart displays make it easy to see. In the context of where it occurred on the chart, this is a bullish key technical reversal in gold. The chart shows the pattern on gold futures. Silver futures traced a similar pattern. Popular ETFs SPDR Gold Shares (GLD) and iShares Silver Trust (SLV) followed. As illustrated on the chart,

WEEKLY MARKET DIGEST: GERMANY TO MOVE SOME OF ITS GOLD BACK HOME $GLD $SLV $USO $DIA $SPY $QQQ $TBF $TBT

January 18, 2013

(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers.) CHINA REBOUNDS January 18, 2013 The fourth quarter GDP in China jumped to 7.9% breaking a streak of seven weaker quarters. For the year, China grew at the slowest rate in more than a decade. Bulls will use GDP number from China and good earnings from GE as justifications for trying to run the market higher. Gold futures are at $1691, silver futures are at $31.97, and oil futures are $95.41. S&P 500 resistance levels are 1480, 1500,

A BOLD CALL TO BUY APPLE THE LOW RISK WAY $AAPL

January 16, 2013

This is a clear bold call to buy Apple in the middle of the doom and gloom that surrounds the stock. However, it is extremely important to buy Apple here the low risk way. The low risk way is to follow the ZYX Change Method. We are in an environment where the noise from talking heads about Apple is deafening. The obvious question is why you should listen to the signal from the ZYX Change Method at this time. The answer lies in the track record. The track record of this method is public and can be easily verified. Specifically,

NEW IDEA ON STJ $STJ

January 16, 2013

This post was just published on ZYX Short Sell Change Alert. Initiating a 10% tranche in STJ in the zone of $38.30 to $39.20. The stock as of this writing is $38.39. The street is misunderstanding the FDA letter for this medical device manufacturer. Target zone $31. to $32. Stop zone $40.26 to $40.62.